Pearson plc (LON:PSON – Get Free Report) insider Sally Johnson sold 63,957 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of GBX 1,174 ($15.68), for a total value of £750,855.18 ($1,002,610.74).
Pearson Trading Down 1.1 %
LON PSON opened at GBX 1,169 ($15.61) on Wednesday. The firm has a market capitalization of £7.89 billion, a PE ratio of 22.66, a price-to-earnings-growth ratio of 0.83 and a beta of 0.31. The business’s 50-day moving average price is GBX 1,211.81 and its two-hundred day moving average price is GBX 1,235.08. The company has a current ratio of 1.78, a quick ratio of 1.07 and a debt-to-equity ratio of 42.49. Pearson plc has a 12 month low of GBX 925.20 ($12.35) and a 12 month high of GBX 1,401 ($18.71).
Pearson (LON:PSON – Get Free Report) last announced its earnings results on Friday, February 28th. The company reported GBX 62.10 ($0.83) EPS for the quarter. Pearson had a return on equity of 8.98% and a net margin of 9.83%.
Pearson Increases Dividend
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. upped their price target on shares of Pearson from GBX 1,400 ($18.69) to GBX 1,450 ($19.36) and gave the company an “overweight” rating in a research report on Tuesday, January 14th.
View Our Latest Stock Report on PSON
Pearson Company Profile
At Pearson, our purpose is simple: to add life to a lifetime of learning. We believe that every learning opportunity is a chance for a personal breakthrough. That’s why our c.20,000 Pearson employees are committed to creating vibrant and enriching learning experiences designed for real-life impact. We are the world’s leading learning company, serving customers in c.200 countries with digital content, assessments, qualifications, and data.
See Also
- Five stocks we like better than Pearson
- Financial Services Stocks Investing
- 3 Mid-Cap Medical Stocks Outperforming the Market
- How to Use High Beta Stocks to Maximize Your Investing Profits
- The Top-Ranked Insider Buys From April by Market Cap
- Ride Out The Recession With These Dividend Kings
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Pearson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pearson and related companies with MarketBeat.com's FREE daily email newsletter.